Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/19/23 → 7/19/26 |
Funding
- Everest Clinical Research Corporation (Prot #SP-1011-005 // Prot #SP-1011-005)
- Ellodi Pharmaceuticals, L.P. (Prot #SP-1011-005 // Prot #SP-1011-005)
Prot #SP‐1011‐005: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Randomized, Double‐blind, Placebo‐Controlled 24‐Week Induction Study of APT‐1011, followed by a Single‐arm Open‐label Extension, in Adult Subjects
- Hirano, Ikuo (PD/PI)
Project: Research project